Developmental Myosin Heavy Chain Regulation and Function
发育性肌球蛋白重链调节和功能
基本信息
- 批准号:6886805
- 负责人:
- 金额:$ 21.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-01 至 2007-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The function of skeletal muscle is to
produce the contractile force necessary for movement. One of the key proteins
involved in muscle contraction is myosin, a hexamer consisting of two heavy
chains and four light chains. Myosin heavy chain (MyHC) contains the motor
domain and the rod domain necessary for thick filament formation. There are 8
known isoforms of MyHC expressed in striated muscle, 2 developmental and 6
adult. While the function and expression of the adult isoforms has been
extensively characterized, relatively little is known about the role of the
embryonic and perinatal skeletal muscle isoforms or of the factors regulating
their expression. Their expression is initiated at mid-gestation, reaches a
peak around birth, and is rapidly down regulated during early postnatal growth
as they are replaced by the adult MyHC isoforms. During the prenatal period,
muscle contraction but no coordinated movement occurs. Thus the exact function
of these isoforms is poorly defined. We propose to evaluate the regulation and
function of the two developmental MyHC isoforms using molecular and genetic
approaches. First, we propose to study the cis- and trans-regulatory factors
governing embryonic and perinatal MyHC expression by functionally analyzing the
upstream regulatory regions of both genes. Promoter activities will be tested
in cell culture and in mice; in the latter, both plasmid DNA injection and
transient transgenics will be used to identify elements necessary for
regulating the magnitude and pattern of expression during muscle development.
Second, we will use homologous recombination to create mice in which either the
embryonic or perinatal MyHC gene has been rendered null and study the resulting
phenotype. Finally, to determine the role of the motor domain of embryonic MyHC
in muscle development, we will create transgenic mice harboring a dominant
mutation in the ATP binding domain. Specifically, we will test the hypothesis
that embryonic MyHC contractile function is necessary for muscle development.
These studies will define the role of the developmental MyHC isoforms in
skeletal muscle form and function.
描述(申请人提供):骨骼肌的功能是
产生运动所需的收缩力量。一种关键的蛋白质
参与肌肉收缩的是肌球蛋白,它是一种由两个重的
链条和四条轻链。肌球蛋白重链(MyHC)含有马达
粗丝形成所需的杆状结构域和杆状结构域。有8个
已知的MyHC亚型在横纹肌中表达,2例发育,6例
成年人。而成体亚型的功能和表达一直是
广泛的特征,相对较少的人知道的作用
胚胎和围产期骨骼肌异构体或调节因子的研究
他们的表情。它们的表达在怀孕中期开始,达到
在出生前后达到高峰,并在出生后早期迅速下降
因为它们被成年的MyHC亚型所取代。在产前,
肌肉收缩,但不会发生协调运动。因此,精确的函数
这些异构体的定义并不明确。我们建议对该法规和
两种发育中的MyHC亚型的分子和遗传学功能
接近了。首先,我们建议研究顺式和跨式调节因素。
通过功能分析调控胚胎和围产期MyHC的表达
这两个基因的上游调控区域。将测试启动子的活性
在细胞培养和小鼠体内;在后者中,质粒DNA注射和
瞬时转基因将被用来确定
在肌肉发育过程中调节表达的大小和模式。
其次,我们将使用同源重组来创造小鼠,在其中
胚胎或围产期MyHC基因已被呈现为空,并研究由此产生的
表型。最后,确定胚胎MyHC的运动域的作用
在肌肉发育方面,我们将创造出具有显性优势的转基因小鼠
三磷酸腺苷结合区突变。具体地说,我们将检验这个假设
胚胎MyHC的收缩功能是肌肉发育所必需的。
这些研究将确定发育中的MyHC亚型在
骨骼肌的形态和功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leslie Anne Leinwand其他文献
Leslie Anne Leinwand的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leslie Anne Leinwand', 18)}}的其他基金
Translating Python Biology to the Mammalian Heart
将Python生物学转化为哺乳动物心脏
- 批准号:
8704090 - 财政年份:2014
- 资助金额:
$ 21.92万 - 项目类别:
Molecular Characterization of Cardiomyopathy Mutations in Human Cardiac Myosin
人心肌肌球蛋白心肌病突变的分子特征
- 批准号:
8584984 - 财政年份:2013
- 资助金额:
$ 21.92万 - 项目类别:
Molecular Characterization of Cardiomyopathy Mutations in Human Cardiac Myosin
人心肌肌球蛋白心肌病突变的分子特征
- 批准号:
9058602 - 财政年份:2013
- 资助金额:
$ 21.92万 - 项目类别:
Molecular Characterization of Cardiomyopathy Mutations in Human Cardiac Myosin
人心肌肌球蛋白心肌病突变的分子特征
- 批准号:
8723276 - 财政年份:2013
- 资助金额:
$ 21.92万 - 项目类别:
Molecular Characterization of Cardiomyopathy Mutations in Human Cardiac Myosin
人心肌肌球蛋白心肌病突变的分子特征
- 批准号:
8843945 - 财政年份:2013
- 资助金额:
$ 21.92万 - 项目类别:
Mechanisms of myopathy caused by mutations in the myosin rod
肌球蛋白杆突变引起的肌病机制
- 批准号:
7260196 - 财政年份:2007
- 资助金额:
$ 21.92万 - 项目类别:
Mechanisms of myopathy caused by mutations in the myosin rod
肌球蛋白杆突变引起的肌病机制
- 批准号:
7406843 - 财政年份:2007
- 资助金额:
$ 21.92万 - 项目类别:
Mechanisms of myopathy caused by mutations in the myosin rod
肌球蛋白杆突变引起的肌病机制
- 批准号:
7587246 - 财政年份:2007
- 资助金额:
$ 21.92万 - 项目类别:
Mechanisms of myopathy caused by mutations in the myosin rod
肌球蛋白杆突变引起的肌病机制
- 批准号:
7789632 - 财政年份:2007
- 资助金额:
$ 21.92万 - 项目类别:
DENVER CARDIOVASCULAR HEALTH EDUCATION ALLIANCE, PHASE I
丹佛心血管健康教育联盟,第一阶段
- 批准号:
6663838 - 财政年份:2002
- 资助金额:
$ 21.92万 - 项目类别:
相似海外基金
CAREER: Elucidating spatial and epigenetic regulation of gene expression during human development using photopatterning and single-cell multiomics
职业:利用光模式和单细胞多组学阐明人类发育过程中基因表达的空间和表观遗传调控
- 批准号:
2339849 - 财政年份:2024
- 资助金额:
$ 21.92万 - 项目类别:
Continuing Grant
CAREER: Scalable algorithms for regularized and non-linear genetic models of gene expression
职业:基因表达的正则化和非线性遗传模型的可扩展算法
- 批准号:
2336469 - 财政年份:2024
- 资助金额:
$ 21.92万 - 项目类别:
Continuing Grant
CAREER: Epigenetic Regulation of Gene Expression in Engineered Prokaryotes
职业:工程原核生物基因表达的表观遗传调控
- 批准号:
2338573 - 财政年份:2024
- 资助金额:
$ 21.92万 - 项目类别:
Continuing Grant
MFB: RNA modifications of frameshifting stimulators: cellular platforms to engineer gene expression by computational mutation predictions and functional experiments
MFB:移码刺激器的RNA修饰:通过计算突变预测和功能实验来设计基因表达的细胞平台
- 批准号:
2330628 - 财政年份:2024
- 资助金额:
$ 21.92万 - 项目类别:
Standard Grant
22-BBSRC/NSF-BIO Building synthetic regulatory units to understand the complexity of mammalian gene expression
22-BBSRC/NSF-BIO 构建合成调控单元以了解哺乳动物基因表达的复杂性
- 批准号:
BB/Y008898/1 - 财政年份:2024
- 资助金额:
$ 21.92万 - 项目类别:
Research Grant
How does the chromatin remodeller CHD4 regulate gene expression?
染色质重塑因子 CHD4 如何调节基因表达?
- 批准号:
DP240102119 - 财政年份:2024
- 资助金额:
$ 21.92万 - 项目类别:
Discovery Projects
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 21.92万 - 项目类别:
Regulation of gene expression by the La and La-related proteins
La 和 La 相关蛋白对基因表达的调节
- 批准号:
489704 - 财政年份:2023
- 资助金额:
$ 21.92万 - 项目类别:
Operating Grants
Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
- 批准号:
494272 - 财政年份:2023
- 资助金额:
$ 21.92万 - 项目类别:
Operating Grants
Application for 2024 CIHR NIF (ECR): Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
2024 CIHR NIF (ECR) 申请:研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
- 批准号:
491942 - 财政年份:2023
- 资助金额:
$ 21.92万 - 项目类别: